116 related articles for article (PubMed ID: 8655902)
1. Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support.
Süttmann U; Ockenga J; Schneider H; Selberg O; Schlesinger A; Gallati H; Wolfram G; Deicher H; Müller MJ
J Am Diet Assoc; 1996 Jun; 96(6):565-9. PubMed ID: 8655902
[TBL] [Abstract][Full Text] [Related]
2. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial.
de Luis Román DA; Bachiller P; Izaola O; Romero E; Martin J; Arranz M; Eiros Bouza JM; Aller R
Eur J Clin Nutr; 2001 Dec; 55(12):1048-52. PubMed ID: 11781670
[TBL] [Abstract][Full Text] [Related]
3. Dietary intake and counseling, weight maintenance, and the course of HIV infection.
Chlebowski RT; Grosvenor M; Lillington L; Sayre J; Beall G
J Am Diet Assoc; 1995 Apr; 95(4):428-32; quiz 433-5. PubMed ID: 7699184
[TBL] [Abstract][Full Text] [Related]
4. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
Luder E; Godfrey E; Godbold J; Simpson DM
J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740
[TBL] [Abstract][Full Text] [Related]
5. High-energy, high-protein, oral, liquid, nutrition supplementation in patients with HIV infection: effect on weight status in relation to incidence of secondary infection.
Stack JA; Bell SJ; Burke PA; Forse RA
J Am Diet Assoc; 1996 Apr; 96(4):337-41. PubMed ID: 8598433
[TBL] [Abstract][Full Text] [Related]
6. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
[TBL] [Abstract][Full Text] [Related]
7. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
[TBL] [Abstract][Full Text] [Related]
8. [Serum levels of soluble tumor necrosis factor receptors as markers for disease progression of human immunodeficiency virus infection].
Hattori M; Tateyama M; Oishi T; Miyasaka S; Fukutake K
Rinsho Byori; 1997 Nov; 45(11):1085-90. PubMed ID: 9396350
[TBL] [Abstract][Full Text] [Related]
9. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis.
Rettammel AL; Marcus MS; Farrell PM; Sondel SA; Koscik RE; Mischler EH
J Am Diet Assoc; 1995 Apr; 95(4):454-9. PubMed ID: 7699188
[TBL] [Abstract][Full Text] [Related]
10. [Serial assessment of the nutritional status of patients infected by the human immunodeficiency virus. Role of tumor necrosis factor/its receptors].
Segura Fernández E; Domenech Cienfuegos I; Pérez Guzmán E; Guerrero Sánchez F; Escribano Moriana JC; Pérez Cano R; Fernández-Gutiérrez del Alamo C; Girón González JA
Rev Clin Esp; 1999 Dec; 199(12):790-5. PubMed ID: 10687411
[TBL] [Abstract][Full Text] [Related]
11. US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function.
Kruzich LA; Marquis GS; Carriquiry AL; Wilson CM; Stephensen CB
J Am Diet Assoc; 2004 Jul; 104(7):1095-101. PubMed ID: 15215767
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study.
Pichard C; Sudre P; Karsegard V; Yerly S; Slosman DO; Delley V; Perrin L; Hirschel B
AIDS; 1998 Jan; 12(1):53-63. PubMed ID: 9456255
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trial.
Chlebowski RT; Beall G; Grosvenor M; Lillington L; Weintraub N; Ambler C; Richards EW; Abbruzzese BC; McCamish MA; Cope FO
Nutrition; 1993; 9(6):507-12. PubMed ID: 8111140
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and immune effects of dietary arginine, glutamine and omega-3 fatty acids supplementation in immunocompromised patients.
Chuntrasakul C; Siltharm S; Sarasombath S; Sittapairochana C; Leowattana W; Chockvivatanavanit S; Bunnak A
J Med Assoc Thai; 1998 May; 81(5):334-43. PubMed ID: 9623033
[TBL] [Abstract][Full Text] [Related]
15. Comparison of specialized and standard enteral formulas in trauma patients.
Brown RO; Hunt H; Mowatt-Larssen CA; Wojtysiak SL; Henningfield MF; Kudsk KA
Pharmacotherapy; 1994; 14(3):314-20. PubMed ID: 7937272
[TBL] [Abstract][Full Text] [Related]
16. Nutritional supplementation in HIV-infected individuals in South India: a prospective interventional study.
Swaminathan S; Padmapriyadarsini C; Yoojin L; Sukumar B; Iliayas S; Karthipriya J; Sakthivel R; Gomathy P; Thomas BE; Mathew M; Wanke CA; Narayanan PR
Clin Infect Dis; 2010 Jul; 51(1):51-7. PubMed ID: 20509768
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
18. The use of novel foods enriched with long-chain n-3 fatty acids to increase dietary intake: a comparison of methodologies assessing nutrient intake.
Patch CS; Tapsell LC; Mori TA; Meyer BJ; Murphy KJ; Mansour J; Noakes M; Clifton PM; Puddey IB; Beilin LJ; Annison G; Howe PR
J Am Diet Assoc; 2005 Dec; 105(12):1918-26. PubMed ID: 16321598
[TBL] [Abstract][Full Text] [Related]
19. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.
Godfried MH; van der Poll T; Jansen J; Romijin JA; Schattenkerk JK; Endert E; van Deventer SJ; Sauerwein HP
AIDS; 1993 Jan; 7(1):33-6. PubMed ID: 8382926
[TBL] [Abstract][Full Text] [Related]
20. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels.
Sutton D; Higgins B; Stevens JM
J Ren Nutr; 2007 Sep; 17(5):329-35. PubMed ID: 17720102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
